CYTK(CYTK)
CYTK
Q4 2026 EPS Estimate
$-1.52
Nov 4, 2026 · Reports after close
Revenue Estimate
$40M
FY2029E EPS$0.82
FY2030E EPS$4.17
Analyst Sentiment
Wall St. Consensus
Buy26 analysts·High coverage
74
Score
25 Buy (96%)1 Hold (4%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
2596%
Hold
14%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$84.00
+8.4%
Consensus
$112.00
+44.6%
Bull
$140.00
+80.7%
12-Month Target Range26 analysts
$84.00$112.00$140.00
Current $77.47Consensus
Current Price
$77.47
Upside to Consensus
$34.53
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+246.25%
EPS—
FY2028
Rev+124.25%
EPS—
FY2029
Rev+72.61%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $114M | $393M | $882M | $1.52B | $2.32B |
| Low | $93M | $321M | $698M | $1.19B | $1.81B |
| High | $192M | $499M | $1.19B | $2.11B | $3.21B |
| EBITDA Avg | $-114M | $-393M | $-882M | $-1.52B | $-2.32B |
| Low | $-192M | $-499M | $-1.19B | $-2.11B | $-3.21B |
| High | $-93M | $-321M | $-698M | $-1.19B | $-1.81B |
| EBIT Avg | $-114M | $-393M | $-882M | $-1.52B | $-2.32B |
| Low | $-192M | $-499M | $-1.19B | $-2.11B | $-3.21B |
| High | $-93M | $-321M | $-698M | $-1.19B | $-1.81B |
| Net Income Avg | $-774M | $-658M | $-333M | $98M | $501M |
| Low | $-841M | $-697M | $-504M | $70M | $359M |
| High | $-501M | $-354M | $13M | $147M | $752M |
| EPS Avg | $-6.32 | $-4.67 | $-2.02 | $0.82 | $4.17 |
| Low | $-7.00 | $-5.80 | $-4.19 | $0.59 | $2.99 |
| High | $-4.17 | $-2.95 | $0.11 | $1.23 | $6.26 |
| Analysts (Rev / EPS) | 16 / 15 | 16 / 15 | 16 / 14 | 14 / 7 | 14 / 11 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $28M | $45M | $56M | $81M | $110M | $148M | $54M | $59M |
| Low | $19M | $26M | $36M | $52M | $70M | $95M | $35M | $37M |
| High | $54M | $66M | $85M | $123M | $167M | $225M | $82M | $89M |
| EBITDA Avg | $-28M | $-45M | $-56M | $-81M | $-110M | $-148M | $-54M | $-59M |
| Low | $-54M | $-66M | $-85M | $-123M | $-167M | $-225M | $-82M | $-89M |
| High | $-19M | $-26M | $-36M | $-52M | $-70M | $-95M | $-35M | $-37M |
| EBIT Avg | $-28M | $-45M | $-56M | $-81M | $-110M | $-148M | $-54M | $-59M |
| Low | $-54M | $-66M | $-85M | $-123M | $-167M | $-225M | $-82M | $-89M |
| High | $-19M | $-26M | $-36M | $-52M | $-70M | $-95M | $-35M | $-37M |
| Net Income Avg | $-206M | $-196M | $-189M | $-189M | $-175M | $-155M | $-180M | $-149M |
| Low | $-227M | $-246M | $-316M | $-315M | $-292M | $-258M | $-300M | $-248M |
| High | $-189M | $-142M | $-100M | $-100M | $-93M | $-82M | $-95M | $-79M |
| EPS Avg | $-1.56 | $-1.48 | $-1.43 | $-1.43 | $-1.32 | $-1.17 | $-1.36 | $-1.12 |
| Low | $-1.72 | $-1.86 | $-2.39 | $-2.39 | $-2.21 | $-1.95 | $-2.27 | $-1.88 |
| High | $-1.43 | $-1.08 | $-0.76 | $-0.76 | $-0.70 | $-0.62 | $-0.72 | $-0.60 |
| Analysts (Rev / EPS) | 12 / 11 | 18 / 16 | 9 / 8 | 9 / 7 | 13 / 7 | 9 / 12 | 16 / 9 | 10 / 8 |